To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
Clinical trial NCT04368507 · COMPLETED
Trial details
- NCT number
- NCT04368507
- Sponsor
- CellabMED
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-09
- Primary completion
- 2021-12-21
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.